Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TARS |
| Upstream (Parents) |
|---|
| (<<) ASNS → TARS |
| (<<) BLNK → TARS |
| (<<) CTSF → TARS |
| (<<) DLAT → TARS |
| (<<) HDAC2 → TARS |
| (<<) IGFBP4 → TARS |
| (<<) MIA3 → TARS |
| (<<) MTHFD2 → TARS |
| (<<) ODC1 → TARS |
| (<<) ORC6L → TARS |
| (<<) PNO1 → TARS |
| (<<) SLC25A32 → TARS |
| (<<) TCEB1 → TARS |
| (<<) TRIB3 → TARS |
| (<<) WBP4 → TARS |
| Downstream (Children) |
|---|
| TARS → CD79A (>>) |
| TARS → FZD8 (>>) |
| TARS → GAL (>>) |
| TARS → MMP17 (>>) |
| TARS → MTRR (>>) |
| TARS → MYO10 (>>) |
| TARS → STC2 (>>) |
